BioSpace News Archive

Business

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results

Artivion, Inc. announced that third quarter 2023 financial results will be released on Thursday, November 2, 2023 after the market closes.

October 19, 2023
·
1 min read
Business

Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2023 Financial Results

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, November 2, 2023, following the release of its third quarter 2023 financial results.

October 19, 2023
·
2 min read
Business

Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 2, 2023

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report third quarter financial results on Thursday, November 2, 2023, after the close of the U.S. financial markets.

October 19, 2023
·
1 min read
Business

Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow

Profound Medical Corp., a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its third quarter 2023 financial results after market close on Thursday, November 2, 2023.

October 19, 2023
·
2 min read
Business

Invitae Appoints Dr. David Sholehvar as Chief Operating Officer

Invitae, a leading medical genetics company, announced the appointment of veteran healthcare leader David Sholehvar, M.D., as chief operating officer, effective November 13, 2023.

October 19, 2023
·
4 min read
Business

Taro to Release Second Quarter Results on October 26, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the second quarter ended September 30, 2023, after the close of market on Thursday, October 26, 2023.

October 19, 2023
·
1 min read
Biotech Bay

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 19, 2023

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 401,220 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

October 19, 2023
·
2 min read
Business

BioLife Solutions Announces Leadership Transitions & Preliminary Third Quarter Revenue with Updated Outlook for 2023

BioLife Solutions, Inc. announced Roderick de Greef has been appointed as Chairman of the Board of Directors and Chief Executive Officer replacing Michael Rice who is retiring after a seventeen year tenure, effective immediately.

October 19, 2023
·
6 min read
NLS Pharmaceuticals to Reschedule Company Update on Strategic Discussions

NLS Pharmaceutics Ltd. announced that it will postpone the company update previously scheduled for Friday, October 20, 2023, due to important developments impacting the timing of the event.

October 19, 2023
·
1 min read
Deals

Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million

Tourmaline Bio, Inc., a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune diseases, announced the completion of its previously announced merger with Talaris Therapeutics, Inc.

October 19, 2023
·
7 min read